Literature DB >> 12938661

[Retinal vein occlusions].

S Dithmar1, L L Hansen, F G Holz.   

Abstract

There are still gaps in understanding the etiology and pathogenesis of circulatory disorders of the central retinal vein. Although various new therapeutic approaches have been developed in the past few years, existing therapy forms are subject to controversy and available data are to some extent inconsistent. This discussion in the German-language literature is associated with varied and nonuniform terminology, which should do justice in particular to concepts of pathomechanism and degree of specificity. The general designation, "occlusion" seems to be the most suitable of all available terms since this implies no conclusions on possible etiological factors. Retinal vein occlusions develop at different sites and to varying extents. Depending on t he location of the occlusion, they can be classified into occlusions of the central vein, hemicentral vein, major branch vein, and macular branch vein. This overview provides information on the current knowledge of the pathogenesis and both established approaches and those in ongoing clinical trials for the treatment of central venous and branch vein occlusions.

Entities:  

Mesh:

Year:  2003        PMID: 12938661     DOI: 10.1007/s00347-003-0820-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  92 in total

1.  Macular grid photocoagulation for macular edema in central retinal vein occlusion.

Authors:  M L Klein; D Finkelstein
Journal:  Arch Ophthalmol       Date:  1989-09

2.  Cilio-retinal infarction after retinal vein occlusion.

Authors:  D McLeod; C P Ring
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

3.  Risk factors for retinal vein occlusions. A case-control study.

Authors:  E Z Rath; R N Frank; D H Shin; C Kim
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

4.  [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].

Authors:  M Reim; B Bertram; S Wolf
Journal:  Klin Wochenschr       Date:  1988

5.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

6.  Cilioretinal artery occlusion in young adults with central retinal vein occlusion.

Authors:  H Schatz; A C Fong; H R McDonald; R N Johnson; L Joffe; C P Wilkinson; J J de Laey; L A Yannuzzi; R T Wendel; B C Joondeph
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

7.  Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion.

Authors:  J F Le Rouic; R A Bejjani; F Rumen; C Caudron; O Bettembourg; G Renard; D Chauvaud
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-10       Impact factor: 3.117

8.  Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase.

Authors:  S S Hayreh; M R Klugman; M Beri; A E Kimura; P Podhajsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

9.  Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein.

Authors:  J N Weiss
Journal:  Am J Ophthalmol       Date:  1998-07       Impact factor: 5.258

10.  Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.

Authors:  D Finkelstein
Journal:  Arch Ophthalmol       Date:  1992-10
View more
  13 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  [Radial optic neurotomy for central retinal vein occlusion -- how deep should it be?].

Authors:  J Wrede; G Varadi; H E Völcker; S Dithmar
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

3.  [Thrombophilic and systemic risk factors in patients with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2011-02       Impact factor: 1.059

4.  [Gingival hyperplasia and visual reduction].

Authors:  M Haustein; J Babatz; F Sommer; J Radke; C Hoffmann; L E Pillunat; D Sandner
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

5.  Retinal vascular occlusions: an interdisciplinary challenge.

Authors:  Alireza Mirshahi; Nicolas Feltgen; Lutz L Hansen; Lars-Olof Hattenbach
Journal:  Dtsch Arztebl Int       Date:  2008-06-27       Impact factor: 5.594

6.  Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study.

Authors:  Nicolas Feltgen; Julia Herrmann; Hansjuergen Agostini; Adel Sammain; Lutz L Hansen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-09       Impact factor: 3.117

Review 7.  [Cardiovascular and hemostaseological view of retinal vascular occlusions].

Authors:  H Seidel; E Stegemann; C Heiss
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

Review 8.  [Surgical treatments for retinal vein occlusion].

Authors:  N Feltgen; H Agostini; L Hansen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

9.  [Retrospective case analysis of ophthalmological and systemic risk factors in patients with retinal vascular occlusion].

Authors:  C Klatt; K Purtskhvanidze; H Hasselbach; F Treumer; J Hillenkamp; J Roider
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

10.  Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.

Authors:  Rita Ehrlich; Thomas A Ciulla; Adam M Moss; Alon Harris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.